From the United Kingdom, Attard et al. reported associations between TMPRSS2-ERG fusion with interstitial deletion and cause specific survival taking into account age, Gleason score, and pre-treatment PSA in a cohort of 445 men conservatively treated for prostate cancer [51]. This evidence concerns the gene TMPRSS2 and Familial prostate cancer.